meganuclease

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases.

Helix will promote Cellectis' Genome Positioning System line of products and services in India.

The French firm gains access to Cyto Pulse's electroporation technologies and equipment.

Cedarlane will distribute Cellectis Bioresearch's kits in Canada.

The patent has been the subject of ongoing litigation between the French and US biotech firms.

The agricultural products company will use Cellectis' meganuclease tools and will invest in the French firm.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.